drugset / Trial / NCT00506129
Allogeneic Transplantation in Patients With Cutaneous T-Cell Lymphoma
NaSingle-groupOpen-labelTreatment
Summary
The goal of this clinical research study is to see if receiving a transplant of blood stem cells (cells that can produce blood) or bone marrow from either a related donor (brother, sister or other relative) or an unrelated voluntary donor will help patients with advanced cutaneous T-cell lymphoma. The length of time that patients who receive the treatment remain free of disease will also be studied.
Timeline
- Start
- 2003-09
- Primary completion
- 2015-06
- Completion
- 2015-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Fludarabine | Small molecule | 25 mg/m2 | Intravenous |
| Background | Melphalan | Small molecule | 70 mg/m2 | Intravenous |
| Background | Thymoglobulin | Protein / enzyme biologic | 2 mg/kg | Intravenous |